Home > Cashflow Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹10,151 Cr₹-2,298 Cr₹-2,780 Cr₹77 Cr₹-1,781 Cr

What is the latest Cash Flow from Financing Activities ratio of TORRENT PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of TORRENT PHARMACEUTICALS is ₹10,151 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹10,151 Cr
Mar2025₹-2,298 Cr
Mar2024₹-2,780 Cr
Mar2023₹77 Cr
Mar2022₹-1,781 Cr

How is Cash Flow from Financing Activities of TORRENT PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹10,151 Cr
Positive
Mar2025 ₹-2,298 Cr
Negative
Mar2024 ₹-2,780 Cr
Negative
Mar2023 ₹77 Cr
Positive
Mar2022 ₹-1,781 Cr -

Compare Cash Flow from Financing Activities of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹188,638.5 Cr 1.2% -2.5% 37.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹463,180.0 Cr 2% -1.7% 15.9% Stock Analytics
DIVIS LABORATORIES ₹243,302.0 Cr 6.5% 14.8% 48.4% Stock Analytics
CIPLA ₹114,554.0 Cr -0.3% -3.9% -11.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,741.0 Cr -2.2% 1.5% -8.3% Stock Analytics
MANKIND PHARMA ₹97,467.0 Cr 1.4% -2.9% -6.7% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

1.2%

-2.5%

37.2%

SENSEX

-0.9%

-1.5%

-5.8%


You may also like the below Video Courses